{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:52:31Z","timestamp":1781110351988,"version":"3.54.1"},"reference-count":28,"publisher":"Jaypee Brothers Medical Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.4103\/ijccm.ijccm_454_16","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T06:05:31Z","timestamp":1495173931000},"page":"317-321","source":"Crossref","is-referenced-by-count":29,"title":["A study of 24 patients with colistin-resistant Gram-negative isolates in a tertiary care hospital in South India"],"prefix":"10.5005","volume":"21","author":[{"given":"Rajalakshmi","family":"Arjun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Senthur","family":"Nambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Madhumitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ramasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","published-online":{"date-parts":[[2017]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, et al. Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006;6:589-601.","DOI":"10.1016\/S1473-3099(06)70580-1"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Antoniadou A, Kontopidou F, Poulakou G, Koratzanis E, Galani I, Papadomichelakis E, et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: First report of a multiclonal cluster. J Antimicrob Chemother 2007;59:786-90.","DOI":"10.1093\/jac\/dkl562"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin 2015;31:707-21.","DOI":"10.1185\/03007995.2015.1018989"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.","DOI":"10.1111\/j.1469-0691.2011.03570.x"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect Dis 2016;16:161-8.","DOI":"10.1016\/S1473-3099(15)00424-7"},{"key":"ref=6","unstructured":"6. Valero E, Sevillano D, Calvo A, Garc\u00eda R, Leturia A, G\u00f3mez-Lus ML. Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii. Rev Esp Quimioter 2001;14:358-63."},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"7. Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: The dawn of the post-antibiotic era? Int J Antimicrob Agents 2007;29:630-6.","DOI":"10.1016\/j.ijantimicag.2006.12.012"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"8. Gales AC, Jones RN, Sader HS. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: Report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 2006;12:315-21.","DOI":"10.1111\/j.1469-0691.2005.01351.x"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. Al-Sweih NA, Al-Hubail MA, Rotimi VO. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals. J Chemother 2011;23:13-6.","DOI":"10.1179\/joc.2011.23.1.13"},{"key":"ref=10","unstructured":"10. Taneja N, Singh G, Singh M, Sharma M. Emergence of tigecycline and colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India. Indian J Med Res 2011;133:681-4."},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Qureshi ZA, Hittle LE, O\u2032Hara JA, Rivera JI, Syed A, Shields RK, et al. Colistin-resistant Acinetobacter baumannii: Beyond carbapenem resistance. Clin Infect Dis 2015;60:1295-303.","DOI":"10.1093\/cid\/civ048"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Chiu SK, Wu TL, Chuang YC, Lin JC, Fung CP, Lu PL, et al. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: The emergence and rapid dissemination of KPC-2 carbapenemase. PLoS One 2013;8:e69428.","DOI":"10.1371\/journal.pone.0069428"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"13. Ghafur A, Vidyalakshmi PR, Murali A, Priyadarshini K, Thirunarayan MA. Emergence of pan-drug resistance amongst gram negative bacteria! The first case series from India. J Microbiol Infect Dis 2014;4:86-91.","DOI":"10.5799\/ahinjs.02.2014.03.0145"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"14. Goel G, Hmar L, Sarkar De M, Bhattacharya S, Chandy M. Colistin-resistant Klebsiella pneumoniae: Report of a cluster of 24 cases from a new oncology center in Eastern India. Infect Control Hosp Epidemiol 2014;35:1076-7.","DOI":"10.1086\/677170"},{"key":"ref=15","unstructured":"15. Ramesh N, Gothandam KM, Prasanth M, Ramkumar S, Karthikeyan S, Bozdogan B, et al. Colistin susceptibility of gram-negative clinical isolates from Tamil Nadu, India. Asian Biomed 2016;10:35-9."},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"16. Mammina C, Bonura C, Di Bernardo F, Aleo A, Fasciana T, Sodano C, et al. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Euro Surveill 2012;17:pii:20248.","DOI":"10.2807\/ese.17.33.20248-en"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"17. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, et al. 2014. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: A rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014;19:pii:20939.","DOI":"10.2807\/1560-7917.ES2014.19.42.20939"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"18. Bogdanovich T, Adams-Haduch JM, Tian GB, Nguyen MH, Kwak EJ, Muto CA, et al. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin Infect Dis 2011;53:373-6.","DOI":"10.1093\/cid\/cir401"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"19. Marchaim D, Chopra T, Pogue JM, Perez F, Hujer AM, Rudin S, et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother 2011;55:593-9.","DOI":"10.1128\/AAC.01020-10"},{"key":"ref=20","unstructured":"20. Heudorf U, Farber D, Mischler D, Schade M, Zinn C, Nillius D, et al. Multidrug-Resistant Organisms (MDRO) in rehabilitation clinics in the Rhine-Main-district, Germany, 2014: Prevalence and risk factors. Rehabilitation (Stuttg) 2015;54:339-45."},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"21. Chen S, Hu F, Zhang X, Xu X, Liu Y, Zhu D, et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatment. J Clin Microbiol 2011;49:4022-3.","DOI":"10.1128\/JCM.01233-11"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"22. Sood S. Chloramphenicol-A potent armament against Multi-Drug Resistant (MDR) gram negative bacilli? J Clin Diagn Res 2016;10:DC01-3.","DOI":"10.7860\/JCDR\/2016\/14989.7167"},{"key":"ref=23","unstructured":"23. Mathur P, Behera B, Chaturvedi D, Misra MC. Chloramphenicol: Is old really gold? J Assoc Physicians India 2010;58:584."},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"24. Civljak R, Giannella M, Di Bella S, Petrosillo N. Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21 st century. Expert Rev Anti Infect Ther 2014;12:249-64.","DOI":"10.1586\/14787210.2014.878647"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"25. Tsioutis C, Kritsotakis EI, Maraki S, Gikas A. Infections by pandrug-resistant gram-negative bacteria: Clinical profile, therapeutic management, and outcome in a series of 21 patients. Eur J Clin Microbiol Infect Dis 2010;29:301-5.","DOI":"10.1007\/s10096-009-0857-7"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"26. Humphries RM, Kelesidis T, Dien Bard J, Ward KW, Bhattacharya D, Lewinski MA. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin. J Med Microbiol 2010;59:1383-6.","DOI":"10.1099\/jmm.0.023010-0"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"27. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: A systematic review. Lancet Infect Dis 2010;10:43-50.","DOI":"10.1016\/S1473-3099(09)70325-1"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"28. Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 2013;19:E23-30.","DOI":"10.1111\/1469-0691.12070"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.4103\/ijccm.IJCCM_454_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T11:14:25Z","timestamp":1622114065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.4103\/ijccm.IJCCM_454_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017]]}},"alternative-id":["10.4103\/ijccm.IJCCM_454_16"],"URL":"https:\/\/doi.org\/10.4103\/ijccm.ijccm_454_16","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}